StockData
Pure Bioscience, Inc. logo

Pure Bioscience, Inc. (PURE) stock

PUREOTCMiscellaneous Chemical ProductsFiscal year ends July 31
Financials through Q4 FY2026, quarter ended Jul 31, 2026Last filing: 10-K on Oct 29, 2026Score 1/30
$0.07−0.01 (-12.10%)

Close on Oct 19, 2026Market cap $8.67MP/E –Yield –

Pure Bioscience r&d expenses

Research and development expenses are spending on new products and technology.

Pure Bioscience's R&D Expenses for the twelve months ending Jul 31, 2026 was $332.00K, up 5.1% year over year. For fiscal 2026 it was $332.00K, up 5.1% from the year before. Over ten years it grew -9.8% a year on average. The highest annual figure on record is $2.18M in fiscal 2011.

Annual r&d expenses

PeriodPeriod endValueChange
FY2026Jul 31, 2026$332.00K+5.1%
FY2025Jul 31, 2025$316.00K+4.6%
FY2024Jul 31, 2024$302.00K+1.7%
FY2023Jul 31, 2023$297.00K-6.9%
FY2022Jul 31, 2022$319.00K-5.9%
FY2021Jul 31, 2021$339.00K+5.3%
FY2020Jul 31, 2020$322.00K-9.0%
FY2019Jul 31, 2019$354.00K-22.9%
FY2018Jul 31, 2018$459.00K-41.1%
FY2017Jul 31, 2017$779.00K-16.0%
FY2016Jul 31, 2016$927.00K+17.3%
FY2015Jul 31, 2015$790.00K-23.4%
FY2014Jul 31, 2014$1.03M-11.7%
FY2013Jul 31, 2013$1.17M-37.3%
FY2012Jul 31, 2012$1.86M-14.5%
FY2011Jul 31, 2011$2.18M–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jul 31, 2026$93.00K+27.4%
Q3 FY2026CQ1 2026Apr 30, 2026$79.00K-13.2%
Q2 FY2026CQ4 2025Jan 31, 2026$74.00K-8.6%
Q1 FY2026CQ3 2025Oct 31, 2025$86.00K+21.1%
Q4 FY2025CQ2 2025Jul 31, 2025$73.00K+5.8%
Q3 FY2025CQ1 2025Apr 30, 2025$91.00K+18.2%
Q2 FY2025CQ4 2024Jan 31, 2025$81.00K+6.6%
Q1 FY2025CQ3 2024Oct 31, 2024$71.00K-11.3%
Q4 FY2024CQ2 2024Jul 31, 2024$69.00K-1.4%
Q3 FY2024CQ1 2024Apr 30, 2024$77.00K+4.1%
Q2 FY2024CQ4 2023Jan 31, 2024$76.00K+1.3%
Q1 FY2024CQ3 2023Oct 31, 2023$80.00K+2.6%
Q4 FY2023CQ2 2023Jul 31, 2023$70.00K+9.4%
Q3 FY2023CQ1 2023Apr 30, 2023$74.00K-30.8%
Q2 FY2023CQ4 2022Jan 31, 2023$75.00K-7.4%
Q1 FY2023CQ3 2022Oct 31, 2022$78.00K+16.4%
Q4 FY2022CQ2 2022Jul 31, 2022$64.00K-13.5%
Q3 FY2022CQ1 2022Apr 30, 2022$107.00K+20.2%
Q2 FY2022CQ4 2021Jan 31, 2022$81.00K-12.9%
Q1 FY2022CQ3 2021Oct 31, 2021$67.00K-19.3%
Q4 FY2021CQ2 2021Jul 31, 2021$74.00K-22.1%
Q3 FY2021CQ1 2021Apr 30, 2021$89.00K+4.7%
Q2 FY2021CQ4 2020Jan 31, 2021$93.00K+55.0%
Q1 FY2021CQ3 2020Oct 31, 2020$83.00K+1.2%
Q4 FY2020CQ2 2020Jul 31, 2020$95.00K-9.5%
Q3 FY2020CQ1 2020Apr 30, 2020$85.00K0.0%
Q2 FY2020CQ4 2019Jan 31, 2020$60.00K-10.4%
Q1 FY2020CQ3 2019Oct 31, 2019$82.00K-15.5%
Q4 FY2019CQ2 2019Jul 31, 2019$105.00K+34.6%
Q3 FY2019CQ1 2019Apr 30, 2019$85.00K-27.4%
Q2 FY2019CQ4 2018Jan 31, 2019$67.00K-44.2%
Q1 FY2019CQ3 2018Oct 31, 2018$97.00K-32.6%
Q4 FY2018CQ2 2018Jul 31, 2018$78.00K-17.9%
Q3 FY2018CQ1 2018Apr 30, 2018$117.00K-47.3%
Q2 FY2018CQ4 2017Jan 31, 2018$120.00K-43.9%
Q1 FY2018CQ3 2017Oct 31, 2017$144.00K-41.9%
Q4 FY2017CQ2 2017Jul 31, 2017$95.00K–
Q3 FY2017CQ1 2017Apr 30, 2017$222.00K–
Q2 FY2017CQ4 2016Jan 31, 2017$214.00K–
Q1 FY2017CQ3 2016Oct 31, 2016$248.00K–

More Pure Bioscience figures

See a number that looks wrong?